Items where Author is "Foster, GR"
Up a level |
Number of items: 11.
2016
Martin, NK;
Vickerman, P;
Dore, GJ;
Grebely, J;
Miners, A;
Cairns, J;
Foster, GR;
Hutchinson, SJ;
Goldberg, DJ;
Martin, TC;
+3 more...
Ramsay, M;
STOP-HCV Consortium;
Hickman, M;
(2016)
How should HCV treatment be prioritized in the direct-acting antiviral era? An economic evaluation including population prevention benefits.
Journal of hepatology, 65 (1).
pp. 17-25.
ISSN 0168-8278
DOI: https://doi.org/10.1016/j.jhep.2016.02.007
Full text not available from this repository.
2014
Martin, NK;
Devine, A;
Eaton, JW;
Miners, A;
Hallett, TB;
Foster, GR;
Dore, GJ;
Easterbrook, PJ;
Legood, R;
Vickerman, P;
(2014)
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.
AIDS (London, England), 28 Sup.
S35-46.
ISSN 0269-9370
DOI: https://doi.org/10.1097/QAD.0000000000000084
Full text not available from this repository.
Martin, NK;
Foster, GR;
Vilar, J;
Ryder, S;
Cramp, ME;
Gordon, F;
Dillon, JF;
Craine, N;
Busse, H;
Clements, A;
+10 more...
Hutchinson, SJ;
Ustianowski, A;
Ramsay, M;
Goldberg, DJ;
Irving, W;
Hope, V;
De Angelis, D;
Lyons, M;
Vickerman, P;
Hickman, M;
(2014)
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.
Journal of viral hepatitis, 22 (4).
pp. 399-408.
ISSN 1352-0504
DOI: https://doi.org/10.1111/jvh.12338
Williams, R;
Aspinall, R;
Bellis, M;
Camps-Walsh, G;
Cramp, M;
Dhawan, A;
Ferguson, J;
Forton, D;
Foster, G;
Gilmore, I;
+15 more...
Hickman, M;
Hudson, M;
Kelly, D;
Langford, A;
Lombard, M;
Longworth, L;
Martin, N;
Moriarty, K;
Newsome, P;
O'Grady, J;
Pryke, R;
Rutter, H;
Ryder, S;
Sheron, N;
Smith, T;
(2014)
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.
Lancet, 384 (9958).
pp. 1953-97.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(14)61838-9
Full text not available from this repository.
2013
Martin, NK;
Vickerman, P;
Clements, A;
Cramp, M;
de Angeles, D;
Dillon, JF;
Fahey, S;
Foster, GR;
Goldberg, DJ;
Gordon, F;
+7 more...
Hutchinson, SJ;
Irving, W;
Lewis, H;
Ryder, S;
Ustainowski, A;
Vilar, J;
Hickman, M;
(2013)
ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS.
[Conference or Workshop Item]
http://researchonline.lshtm.ac.uk/id/eprint/1229346
Full text not available from this repository.
Martin, NK;
Vickerman, P;
Grebely, J;
Hellard, M;
Hutchinson, SJ;
Lima, VD;
Foster, GR;
Dillon, JF;
Goldberg, DJ;
Dore, GJ;
+1 more...
Hickman, M;
(2013)
HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.
Hepatology (Baltimore, Md), 58 (5).
pp. 1598-609.
ISSN 0270-9139
DOI: https://doi.org/10.1002/hep.26431
Full text not available from this repository.
Martin, NatashaK;
Vickerman, Peter;
Grebely, Jason;
Hellard, Margaret;
Hutchinson, SharonJ;
Lima, VivianeD;
Foster, GrahamR;
Dillon, JohnF;
Goldberg, DavidJ;
Dore, GregoryJ;
+1 more...
Hickman, Matthew;
(2013)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals.
Hepatology (Baltimore, Md), 58 (5).
pp. 1598-1609.
ISSN 0270-9139
DOI: https://doi.org/10.1002/hep.26431
2012
Harris, RJ;
Ramsay, M;
Hope, VD;
Brant, L;
Hickman, M;
Foster, GR;
De Angelis, D;
(2012)
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
European journal of public health, 22 (2).
pp. 187-92.
ISSN 1101-1262
DOI: https://doi.org/10.1093/eurpub/ckr083
Full text not available from this repository.
2011
Martin, NK;
Vickerman, P;
Foster, GR;
Hutchinson, SJ;
Goldberg, DJ;
Hickman, M;
(2011)
Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.
Journal of hepatology, 54 (6).
pp. 1137-44.
ISSN 0168-8278
DOI: https://doi.org/10.1016/j.jhep.2010.08.029
Full text not available from this repository.
Martin, NK;
Vickerman, P;
Miners, A;
Foster, GR;
Hutchinson, SJ;
Goldberg, DJ;
Hickman, M;
(2011)
The cost-effectiveness of HCV antiviral treatment for injecting drug user populations.
Hepatology (Baltimore, Md), 55 (1).
pp. 49-57.
ISSN 0270-9139
DOI: https://doi.org/10.1002/hep.24656
Full text not available from this repository.
2010
Martin, NK;
Vickerman, P;
Foster, GR;
Hutchinson, S;
Goldberg, DJ;
Hickman, M;
(2010)
Can Antiviral Therapy for Hepatitis C Reduce the Prevalence of Hcv among Injecting Drug User Populations? A Modeling Analysis of Its Prevention Utility.
[Conference or Workshop Item]
http://researchonline.lshtm.ac.uk/id/eprint/893
Full text not available from this repository.